499 assets in Hepatocellular Carcinoma

Therapeutic assets addressing Hepatocellular Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
R130 Hepatocellular Carcinoma	Shanghai Yunying Medical Technology	Early P1	C (38)
Sasanlimab Hepatocellular Carcinoma	NiKang Therapeutics, Inc.	P2	C (38)
21.15.gpc3-car t cells Hepatocellular Carcinoma	Baylor College of Medicine	P1	C (37)
Abbv-400 Hepatocellular Carcinoma	AbbVie	P1	C (37)
Acc-1898 Hepatocellular Carcinoma	AccSalus Biosciences, Inc.	P1	C (37)
ai-061 Hepatocellular Carcinoma	OncoC4, Inc.	P1	C (37)
Autologous Memory Lymphocyte Hepatocellular Carcinoma	Newish Technology (Beijing) Co., Ltd.	P1	C (37)
Bay 3547922 Hepatocellular Carcinoma	Bayer	P1	C (37)
Bay 3547926 Hepatocellular Carcinoma	Bayer	P1	C (37)
Bay 3713391 Hepatocellular Carcinoma	Bayer	P1	C (37)
Cardonilimab Hepatocellular Carcinoma	Peking Union Medical College Hospital	P1	C (37)
C-Car031 Hepatocellular Carcinoma	Zhejiang University	P1	C (37)
Chs-006 Hepatocellular Carcinoma	Coherus Oncology, Inc.	P1	C (37)
Cpg-Odn Hepatocellular Carcinoma	Second Affiliated Hospital of Guangzhou Medical University	P1	C (37)
CRX100 Hepatocellular Carcinoma	BioEclipse Therapeutics	P1	C (37)
etn101 Hepatocellular Carcinoma	Etnova Therapeutics Corp.	P1	C (37)
Fapi-46 Hepatocellular Carcinoma	National University Hospital, Singapore	P1	C (37)
FXB0871 Hepatocellular Carcinoma	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	P1	C (37)
Hbv Mrna Vaccine Hepatocellular Carcinoma	West China Hospital	P1	C (37)
Hcv Dna Vaccine Ino-8000 Hepatocellular Carcinoma	National Cancer Institute (NCI)	P1	C (37)
hh160 Hepatocellular Carcinoma	Huahui Health	P1	C (37)
Idov-Immune Hepatocellular Carcinoma	ViroMissile, Inc.	P1	C (37)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Tnfrsf4 (Tumor Necrosis Factor Receptor (Tnfr) Superfamily Member 4, Ox40, Cd134)], Homo Sapiens Monoclonal Antibody Hepatocellular Carcinoma	HiFiBiO Therapeutics	P1	C (37)
Itraconazole Hepatocellular Carcinoma	AbbVie	P1	C (37)
jmt106 Hepatocellular Carcinoma	Shanghai JMT-Bio Inc.	P1	C (37)
Liocyx-M, Hbv Antigen-Specific Tcr-Redirected T Cells Hepatocellular Carcinoma	Lion TCR Pte. Ltd.	P1	C (37)
MGC026 Hepatocellular Carcinoma	MacroGenics	P1	C (37)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Hepatocellular Carcinoma	City of Hope Medical Center	P1	C (37)
Montanide Isa 51 Hepatocellular Carcinoma	National Cancer Institute, Naples	P1	C (37)
Mrna Hbv/Tcr T-Cells Hepatocellular Carcinoma	Lion TCR Pte. Ltd.	P1	C (37)
mt-303 Hepatocellular Carcinoma	Myeloid Therapeutics	P1	C (37)
mt-8421 Hepatocellular Carcinoma	Molecular Templates, Inc.	P1	C (37)
Naptumomab Estafenatox Hepatocellular Carcinoma	NeoTX Therapeutics Ltd.	P1	C (37)
Nocardia Rubra Cell Wall Skeleton Hepatocellular Carcinoma	Wan-Guang Zhang	P1	C (37)
np-101 Hepatocellular Carcinoma	University of Florida	P1	C (37)
np137 Hepatocellular Carcinoma	University Hospital, Grenoble	P1	C (37)
pb101 Hepatocellular Carcinoma	Panolos Bioscience	P1	C (37)
pf-08046054 Hepatocellular Carcinoma	Seagen, a wholly owned subsidiary of Pfizer	P1	C (37)
PIN Hepatocellular Carcinoma	Chinese PLA General Hospital	P1	C (37)
QXL138AM Hepatocellular Carcinoma	Nammi Therapeutics Inc	P1	C (37)
Rd-Cy7 Fluorophore Hepatocellular Carcinoma	Institute of Automation, Chinese Academy of Sciences	P1	C (37)
Rocakinogene Sifuplasmid Hepatocellular Carcinoma	National Cancer Institute (NCI)	P1	C (37)
Sc-Car.Gpc3Xil15.21 Car T Cells Hepatocellular Carcinoma	Seattle Children's Hospital	P1	C (37)
Selinexor Hepatocellular Carcinoma	H. Lee Moffitt Cancer Center and Research Institute	P1	C (37)
sim0610 for Hepatocellular Carcinoma	Jiangsu Simcere Pharmaceutical Co., Ltd.	P1	C (37)
S,S-Adenosylmethionine Hepatocellular Carcinoma	Shanghai Zhongshan Hospital	P1	C (37)
Synov1.1 Hepatocellular Carcinoma	Beijing Syngentech Co., Ltd.	P1	C (37)
Torl-4-500 Hepatocellular Carcinoma	TORL Biotherapeutics, LLC	P1	C (37)
Ymn-A02 Hepatocellular Carcinoma	West China Hospital	P1	C (37)
zw251 Hepatocellular Carcinoma	Zymeworks BC Inc.	P1	C (37)

Showing 401 to 450 of 499 assets

PreviousPage 9 of 10Next